2m 2m 2m 2m 2m 2m 2m
Lexaria Bioscien (LEXX)
NASDAQ
$0.58+$0.02 (+2.91%)
Price as of Jun 24, 2026 4:00 AM EDT- $14.4MMarket Cap
- -40.26%1-Year Change
- BiotechnologyIndustry
Lexaria Bioscien (LEXX)
$0.58+$0.02 (+2.91%)
LEXX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.57 | ||
Change | -$0.02 (-2.63%) | ||
Open | $0.60 | ||
High | $0.61 | ||
Low | $0.56 | ||
Previous Close | $0.58 | ||
Volume | 49,360 | ||
30-Day Average Volume | 81,238 | ||
1-Week Change | -3.65% | ||
1-Month Change | -12.69% | ||
1-Year Change | -40.26% | ||
3-Year Change | -28.20% | ||
5-Year Change | -91.45% | ||
Fundamentals | |||
Shares Outstanding | 24.8M | ||
Total Assets | $6.5M | ||
Market Cap | $14.4M | ||
Enterprise Value | $9.3M | ||
Period: QTR TTM FY | |||
Revenue | $20,000.00 | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$2.2M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | $5.6M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 466 | ||
P/B | 2 | ||
P/E | -10 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue